357.40DKK-4.69%Mkt Cap: 6.22B DKKP/E: 35.18Last update: 2026-06-01
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap6.22B DKK
Enterprise Value6.26B DKK
Revenue (TTM)493.12M DKK
Gross Profit465.51M DKK
Net Income (TTM)186.41M DKK
Revenue/Share28.33 DKK
Last Price357.40 DKK
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees172
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINDK0060055861
Valuation
P/E (Trailing)35.18
P/E (Forward)29.45
PEG—
EV/EBITDA25.62
EV/Revenue12.69
P/S13.23
P/B10.00
EPS (TTM)10.19
EPS (Forward)12.73
52W Range
235.2021% of range804.00
52W High804.00 DKK
52W Low235.20 DKK
Profitability
Gross Margin93.93%
Oper. Margin48.42%
EBITDA Margin49.51%
Profit Margin37.61%
ROE27.68%
ROA22.51%
Growth
Revenue Growth-1.00%
Earnings Growth-9.10%
Cash Flow & Leverage
Operating CF207.45M DKK
CapEx (TTM)64.73M DKK
FCF Margin25.06%
FCF Yield1.99%
Net Debt-269.45M DKK
Net Debt/EBITDA-1.10
Balance Sheet
Debt/Equity0.01
Current Ratio3.93
Quick Ratio3.02
Book Value/Sh37.50 DKK
Cash/Share15.78 DKK
Dividends
Fwd Div Rate7.000 DKK
Trail. Div Rate7.000 DKK
Div. Yield1.97%
5Y Avg Yield—
Payout Ratio68.83%
Ex-Div DateOct 10, 2025
Pay Date—
Analyst Consensus
Rating—
Target (Mean)546.25 DKK
Target Range450.00 DKK – 650.00 DKK
# Analysts4
Ownership
Shares Out.17.40M
Float16.74M
Insiders3.73%
Institutions53.13%
Technical
SMA 50323.35 (+10.5%)
SMA 200546.31 (-34.6%)
Beta1.33
S&P 52W Chg27.94%
Avg Vol (30d)77.74K
Avg Vol (10d)64.26K
Technical Indicators
RSI (14)67.4
MACD6.3920
MACD Signal-0.0303
MACD Hist.+6.4222
BB Upper365.35 DKK
BB Middle330.19 DKK
BB Lower295.03 DKK
BB Width21.30%
ATR (14)16.01 DKK
Vol Ratio (20d)2.97x